Genki Yamato

14PUBLICATIONS
74CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Regenerative medicine (incl. stem cells)Medical molecular engineering of nucleic acids and proteinsNanotoxicology, health and safetyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 10, 2026
Multiomics analysis focusing on genome-wide DNA methylation in paediatric acute promyelocytic leukaemia.

|Aug 05, 2024
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan.

Shota Kato, Kentaro Nakashima, Genki Yamato

|Jul 02, 2024
High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial.

Masahiro Yoshitomi, Shin-Ichi Tsujimoto, Junji Ikeda

|May 01, 2024
Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial.

Genki Yamato, Yusuke Tsumura, Hideki Muramatsu

|Mar 21, 2024
Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms.

Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki

|Dec 06, 2023
High IL2RA/CD25 expression is a prognostic stem cell biomarker for pediatric acute myeloid leukemia without a core-binding factor.

Takahiro Aoki, Norio Shiba, Shinichi Tsujimoto

Pageof 3

Frequent Collaborators

8 joint publications

Daisuke Tomizawa

5 joint publications

Takashi Taga

4 joint publications

Yusuke Hara

3 joint publications

Etsuro Ito